Sarepta Therapeutics, Inc. Logo

Sarepta Therapeutics, Inc.

Develops precision genetic medicines for rare neuromuscular disorders.

SRPT | US

Overview

Corporate Details

ISIN(s):
US8036071004
LEI:
Country:
United States of America
Address:
215 FIRST STREET, 2142 CAMBRIDGE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sarepta Therapeutics, Inc. is a global biotechnology company focused on engineering precision genetic medicines to treat rare diseases. The company's primary mission is to develop therapies for conditions with few or no treatment options, with a significant focus on neuromuscular disorders like Duchenne muscular dystrophy, limb-girdle muscular dystrophy, and Charcot-Marie-Tooth disease. Sarepta utilizes advanced scientific platforms, including RNA-targeted technologies, gene therapy, and gene editing. It has multiple FDA-approved treatments and maintains a pipeline of over 40 programs. The company is also focused on accelerating drug development timelines and building large-scale gene therapy manufacturing capacity to support patient access.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Sarepta Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sarepta Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sarepta Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HLB INC. Logo
A diversified group in pharma, shipbuilding, life sciences, and professional advisory services.
South Korea
028300
HLB Life Science CO.,LTD. Logo
Develops anti-cancer drugs and distributes IVD medical devices and lab supplies internationally.
South Korea
067630
HLB PANAGENE Co., LTD. Logo
A global leader in PNA technology for cancer diagnostics and precision medicine.
South Korea
046210
HLB Pep Co., Ltd. Logo
Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.
South Korea
196300
HLB PHARMACEUTICAL CO., LTD. Logo
Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.
South Korea
047920
HLB SCIENCE Inc. Logo
Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.
South Korea
343090
H. Lundbeck A Logo
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark
HLUN
Hoth Therapeutics, Inc. Logo
Advancing therapeutics for metabolic, dermatologic, and inflammatory diseases.
United States of America
HOTH
Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.
South Korea
145020
Humacyte, Inc. Logo
Bioengineering off-the-shelf human tissues for vascular repair and regenerative medicine.
United States of America
HUMA

Talk to a Data Expert

Have a question? We'll get back to you promptly.